John P. Kenny - 24 Jun 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffery T. Pinkston as Attorney-in-fact for John P. Kenny
Issuer symbol
VIVO
Transactions as of
24 Jun 2022
Transactions value $
-$1,516,165
Form type
4
Filing time
28 Jun 2022, 09:42:43 UTC
Previous filing
24 Jun 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Options Exercise $136,945 +13,559 +5.11% $10.1 278,690 24 Jun 2022 Direct
transaction VIVO Common Stock Sale -$406,836 -13,559 -4.87% $30 265,131 24 Jun 2022 Direct F1, F2
transaction VIVO Common Stock Options Exercise $620,513 +61,437 +23.17% $10.1 326,568 27 Jun 2022 Direct
transaction VIVO Common Stock Sale -$1,866,787 -61,437 -18.81% $30.39 265,131 27 Jun 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Options (Right to Buy) Options Exercise $0 -13,559 -9.61% $0 127,476 24 Jun 2022 Common Stock 13,559 $10.1 Direct F5, F6
transaction VIVO Stock Options (Right to Buy) Options Exercise $0 -61,437 -48.19% $0 66,039 27 Jun 2022 Common Stock 61,437 $10.1 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.11. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.
F4 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.76. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
F5 The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.
F6 These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date.
F7 The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.